iTeos Therapeutics, Inc. (ITOS)
NASDAQ: ITOS · Real-Time Price · USD
6.67
-0.04 (-0.52%)
At close: May 9, 2025, 4:00 PM
6.73
+0.07 (0.98%)
After-hours: May 9, 2025, 7:34 PM EDT
iTeos Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Cash & Equivalents | 156.54 | 142.13 | 251.18 | 284.8 | 848.54 | 336.33 | Upgrade
|
| Short-Term Investments | 363.83 | 352.52 | 280.74 | 328.36 | - | - | Upgrade
|
| Cash & Short-Term Investments | 520.37 | 494.65 | 531.92 | 613.16 | 848.54 | 336.33 | Upgrade
|
| Cash Growth | 15.86% | -7.01% | -13.25% | -27.74% | 152.30% | 1592.80% | Upgrade
|
| Other Receivables | 3.27 | 3.69 | 6.5 | 2.44 | 12.09 | 0.33 | Upgrade
|
| Receivables | 3.27 | 3.69 | 6.5 | 2.44 | 12.09 | 0.33 | Upgrade
|
| Prepaid Expenses | 13.41 | 11.2 | 12.24 | 12.7 | 14.09 | 2.89 | Upgrade
|
| Total Current Assets | 537.05 | 509.54 | 550.65 | 628.3 | 874.71 | 339.54 | Upgrade
|
| Property, Plant & Equipment | 10.1 | 9.98 | 10.73 | 6.77 | 7.4 | 1.35 | Upgrade
|
| Long-Term Investments | 103.92 | 160.35 | 100.54 | 118.23 | - | - | Upgrade
|
| Other Long-Term Assets | 7.81 | 7.1 | 5.67 | 1.7 | 2.6 | 3.66 | Upgrade
|
| Total Assets | 658.87 | 686.98 | 667.59 | 754.99 | 884.71 | 344.56 | Upgrade
|
| Accounts Payable | 14 | 8.5 | 11.29 | 7.66 | 5.15 | 3.03 | Upgrade
|
| Accrued Expenses | 21.05 | 29.12 | 15.62 | 19.73 | 17.16 | 7.49 | Upgrade
|
| Current Portion of Leases | 1.41 | 1.34 | 1.25 | 0.84 | 0.77 | - | Upgrade
|
| Current Unearned Revenue | 1.54 | 1.4 | 2.06 | 13.78 | 281.05 | 4.49 | Upgrade
|
| Other Current Liabilities | - | - | 9.79 | - | - | - | Upgrade
|
| Total Current Liabilities | 38 | 40.36 | 40.01 | 42 | 304.12 | 15 | Upgrade
|
| Long-Term Leases | 3.64 | 3.76 | 4.81 | 3.84 | 4.57 | - | Upgrade
|
| Other Long-Term Liabilities | 53.81 | 52.56 | 47.54 | 45.82 | 23.2 | 6.36 | Upgrade
|
| Total Liabilities | 95.45 | 96.68 | 92.36 | 91.66 | 331.89 | 21.36 | Upgrade
|
| Common Stock | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | Upgrade
|
| Additional Paid-In Capital | 622.7 | 616.04 | 463.8 | 435.67 | 413.18 | 396.44 | Upgrade
|
| Retained Earnings | -44.39 | -9.78 | 124.63 | 237.28 | 140.62 | -73.9 | Upgrade
|
| Comprehensive Income & Other | -14.92 | -16 | -13.24 | -9.64 | -1.02 | 0.62 | Upgrade
|
| Total Common Equity | 563.42 | 590.29 | 575.23 | 663.33 | 552.82 | 323.2 | Upgrade
|
| Shareholders' Equity | 563.42 | 590.29 | 575.23 | 663.33 | 552.82 | 323.2 | Upgrade
|
| Total Liabilities & Equity | 658.87 | 686.98 | 667.59 | 754.99 | 884.71 | 344.56 | Upgrade
|
| Total Debt | 5.05 | 5.1 | 6.06 | 4.67 | 5.34 | - | Upgrade
|
| Net Cash (Debt) | 515.32 | 489.55 | 525.86 | 608.49 | 843.2 | 336.33 | Upgrade
|
| Net Cash Growth | 16.24% | -6.90% | -13.58% | -27.83% | 150.71% | 1592.80% | Upgrade
|
| Net Cash Per Share | 12.18 | 12.10 | 14.70 | 16.11 | 22.32 | 22.30 | Upgrade
|
| Filing Date Shares Outstanding | 38.27 | 38.19 | 35.84 | 35.72 | 35.51 | 35.1 | Upgrade
|
| Total Common Shares Outstanding | 38.27 | 36.57 | 35.84 | 35.61 | 35.47 | 35.04 | Upgrade
|
| Working Capital | 499.05 | 469.18 | 510.64 | 586.3 | 570.59 | 324.55 | Upgrade
|
| Book Value Per Share | 14.72 | 16.14 | 16.05 | 18.63 | 15.59 | 9.22 | Upgrade
|
| Tangible Book Value | 563.42 | 590.29 | 575.23 | 663.33 | 552.82 | 323.2 | Upgrade
|
| Tangible Book Value Per Share | 14.72 | 16.14 | 16.05 | 18.63 | 15.59 | 9.22 | Upgrade
|
| Machinery | 6.12 | 5.76 | 4.9 | 4.34 | 3.97 | 3.16 | Upgrade
|
| Leasehold Improvements | 4.27 | 4.05 | 4.18 | 1.24 | 1.07 | 0.86 | Upgrade
|
Updated Mar 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.